Global Yeast Expression System Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Yeast Expression System Market Research Report 2024
Yeast expression systems are a type of recombinant protein expression system used to produce large quantities of proteins for research and industrial applications. Yeast expression systems are based on the use of genetically engineered strains of yeast, typically Saccharomyces cerevisiae, to express foreign genes and produce proteins.
According to MRAResearch’s new survey, global Yeast Expression System market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Yeast Expression System market research.
The global market for Yeast Expression Systems has been experiencing steady growth, driven by the increasing demand for recombinant proteins in various industries, including biopharmaceuticals, research, and industrial applications. The Yeast Expression System offers advantages such as high protein yields, eukaryotic post-translational modifications, and scalability. The United States and Canada have a strong presence in the Yeast Expression System market, driven by a robust biotechnology sector and significant investments in research and development. European countries have a prominent role in both academic research and industrial applications of the Yeast Expression System. The region has a history of utilizing yeast for protein production. Asia-Pacific is experiencing growth in the Yeast Expression System market, driven by increasing research activities, biopharmaceutical development, and the expansion of the industrial biotechnology sector. The Yeast Expression System market is expected to continue growing as the demand for recombinant proteins and biologics rises. Advances in yeast strain engineering, fermentation technologies, and protein purification techniques are likely to enhance the capabilities of the Yeast Expression System. Additionally, the trend towards personalized medicine and the need for efficient protein production are expected to drive the adoption of Yeast Expression Systems in the coming years.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Yeast Expression System market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Thermo Fisher Scientific
Merck Group
Agilent Technologies
GenScript Biotech
Biocompare
IBA Lifesciences
Bio Basic
ProteoGenix
Creative BioMart
Takara Bio
Genosphere Biotechnologies
Invitrogen
Profacgen
Sino Biological
Hangzhou Clongene Biotech
Segment by Type
Saccharomyces Cerevisiae
Pichia Pastoris
Others
Drugs Development
Biomedical Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Yeast Expression System report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Yeast Expression System market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Yeast Expression System market research.
The global market for Yeast Expression Systems has been experiencing steady growth, driven by the increasing demand for recombinant proteins in various industries, including biopharmaceuticals, research, and industrial applications. The Yeast Expression System offers advantages such as high protein yields, eukaryotic post-translational modifications, and scalability. The United States and Canada have a strong presence in the Yeast Expression System market, driven by a robust biotechnology sector and significant investments in research and development. European countries have a prominent role in both academic research and industrial applications of the Yeast Expression System. The region has a history of utilizing yeast for protein production. Asia-Pacific is experiencing growth in the Yeast Expression System market, driven by increasing research activities, biopharmaceutical development, and the expansion of the industrial biotechnology sector. The Yeast Expression System market is expected to continue growing as the demand for recombinant proteins and biologics rises. Advances in yeast strain engineering, fermentation technologies, and protein purification techniques are likely to enhance the capabilities of the Yeast Expression System. Additionally, the trend towards personalized medicine and the need for efficient protein production are expected to drive the adoption of Yeast Expression Systems in the coming years.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Yeast Expression System market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Thermo Fisher Scientific
Merck Group
Agilent Technologies
GenScript Biotech
Biocompare
IBA Lifesciences
Bio Basic
ProteoGenix
Creative BioMart
Takara Bio
Genosphere Biotechnologies
Invitrogen
Profacgen
Sino Biological
Hangzhou Clongene Biotech
Segment by Type
Saccharomyces Cerevisiae
Pichia Pastoris
Others
Segment by Application
Drugs Development
Biomedical Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Yeast Expression System report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source